Chorea is the hallmark movement symptom of Huntington’s disease: involuntary, irregular, dance-like movements that flow unpredictably from one body part to another. The word itself comes from the Greek word for “dance,” and watching someone with chorea, you can see why. The movements aren’t rhythmic or repetitive like a tremor. They look almost purposeful, as if the person is fidgeting or shifting restlessly, but they’re entirely outside voluntary control.
What Chorea Looks and Feels Like
Chorea in Huntington’s disease typically starts small. The earliest signs often appear in the fingers, toes, and face as brief, subtle twitches or flickers that can be easy to dismiss or hide. A person might seem restless, or incorporate the movements into normal gestures to mask them. Over time, the movements spread to larger, more central muscle groups including the trunk, shoulders, and hips, and they grow in amplitude.
The movements intensify when a person is anxious, distracted, or trying to concentrate on something else. They generally disappear during sleep. As the disease progresses, chorea can become dramatic enough to interfere with walking, eating, dressing, and virtually every activity of daily life. Holding objects becomes unreliable. Eating without assistance gets harder as facial and throat muscles are affected. Falls become a serious concern as the trunk and legs are involved.
Chorea also carries a significant physical cost. The constant involuntary movement burns calories at an unusually high rate, which contributes to the progressive weight loss that many people with Huntington’s experience. Maintaining adequate nutrition becomes an active challenge, not just because of difficulty swallowing but because the body’s energy demands are relentlessly elevated.
Why the Brain Produces These Movements
Chorea results from damage to a specific circuit deep in the brain called the basal ganglia, which normally acts as a gatekeeper for movement. In a healthy brain, one set of nerve cells (the “indirect pathway”) works to suppress unwanted movements. Huntington’s disease selectively destroys these suppressor cells early in its course.
When these cells die off, downstream relay stations in the brain become hyperactive, firing at two to three times their normal rate. The result is that movements that should be filtered out instead get released. It’s essentially a failure of the brain’s braking system. The chemical messenger dopamine, which promotes movement, ends up with outsized influence because the cells that normally counterbalance it are gone. This imbalance is why the primary medications for chorea work by dialing down dopamine signaling.
How Chorea Changes Over Time
One of the less intuitive things about Huntington’s chorea is that it doesn’t simply get worse in a straight line. In the early and middle stages of the disease, chorea is the dominant movement problem, peaking in intensity somewhere in the middle stages. But as the disease advances into later stages, chorea often fades and is gradually replaced by rigidity, slowness of movement, and sustained abnormal postures (dystonia).
This shift reflects the progressive loss of additional brain circuits beyond the initial indirect pathway. Early on, only the movement-suppressing cells are damaged, so you see too much movement. Later, the movement-promoting cells are lost too, and the person becomes increasingly stiff and slow. Some people with Huntington’s experience both chorea and slowness simultaneously, even relatively early in the disease. A smaller number of individuals, particularly those with juvenile-onset Huntington’s, may never develop prominent chorea at all, instead presenting primarily with rigidity from the start.
The balance between chorea and rigidity varies considerably from person to person, which is one reason Huntington’s disease can look quite different across individuals even at similar stages.
How Chorea Is Measured
Clinicians track chorea severity using the Unified Huntington’s Disease Rating Scale (UHDRS), which includes a detailed motor assessment. The motor section covers 31 items evaluating eye movements, slowness, rigidity, dystonia, chorea, gait, and balance. Each item is scored from zero (normal) to four (severe), producing a Total Motor Score that ranges from 0 to 124. This standardized scoring allows doctors to monitor progression over time and evaluate whether treatments are helping.
Chorea is rated separately in different body regions (face, trunk, and each limb), so the assessment captures not just overall severity but also how widely the movements have spread.
Treatments That Reduce Chorea
Two FDA-approved medications specifically target chorea in Huntington’s disease. Both work by reducing the amount of dopamine available in movement circuits, essentially compensating for the lost braking cells by turning down the accelerator instead.
The first, approved in 2008, was the earlier formulation, which needs to be taken up to three times daily. A newer version, approved in 2017, uses a chemical modification that lets the drug last longer in the body, allowing twice-daily dosing and generally producing fewer side effects like drowsiness and depression. Both can meaningfully reduce chorea severity, though they don’t slow the underlying disease progression.
Some antipsychotic medications are used as second-line options. These drugs block dopamine receptors directly rather than depleting dopamine, and they can reduce chorea while also helping with psychiatric symptoms like irritability or psychosis that often accompany Huntington’s. The tradeoff is a broader side effect profile, including sedation and metabolic changes.
Deciding whether to treat chorea with medication isn’t automatic. Mild chorea that doesn’t interfere with function may not need treatment, especially since these medications can cause drowsiness or worsen the slowness and rigidity that emerge later. Treatment decisions typically hinge on how much the chorea disrupts daily life, causes injury risk, or distresses the person experiencing it.
Physical Activity and Rehabilitation
Exercise and structured rehabilitation programs have shown meaningful benefits for people living with Huntington’s chorea. Studies of multidisciplinary therapy programs, combining physical therapy, occupational therapy, and structured exercise, have found improvements in gait, motor function, and overall quality of life. Participants in intensive rehabilitation programs also showed reductions in anxiety and depression, which frequently coexist with the motor symptoms.
Physical therapy for chorea focuses on practical goals: maintaining safe mobility, reducing fall risk, preserving the ability to perform daily tasks, and adapting the home environment as movements become more pronounced. Occupational therapists can recommend weighted utensils, adapted clothing, and other tools that help people maintain independence longer. The specific recommendations evolve as the balance between chorea and rigidity shifts over the course of the disease.
Chorea Alongside Other Motor Symptoms
Chorea rarely exists in isolation. Most people with Huntington’s also develop some combination of dystonia (sustained, twisting postures), slowness of voluntary movement, impaired eye movements, and balance problems. Research has confirmed that slowness is an independent feature of Huntington’s disease, not simply a side effect of medications used to treat chorea. Brain recordings show that the muscle activation patterns during slow movements in Huntington’s are distinct from those seen in Parkinson’s disease, even though both conditions involve the basal ganglia.
This overlap matters practically because treating one symptom can worsen another. Reducing chorea with medication may unmask or amplify the underlying rigidity and slowness. The goal of treatment is finding the combination that preserves the most function and comfort, which requires ongoing adjustment as the disease evolves.